Thalidomide-type teratogenicity: structure–activity relationships for congeners

Thalidomide-induced teratogenesis: History and mechanisms

(2015) Neil Vargesson   BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS

Enantiomerization Mechanism of Thalidomide and the Role of Water and Hydroxide Ions

(2012) Chuanjin Tian et al.   CHEMISTRY-A EUROPEAN JOURNAL

Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease

(2011) James H. Kim et al.   TOXICOLOGICAL SCIENCES

Racemates revisited: heterochiral assemblies and the example ofdl-thalidomide

(2011) David E. Hague et al.   XENOBIOTICA

Evaluation of stability difference between asymmetric homochiral dimer in (S)-thalidomide crystal and symmetric heterochiral dimer in (RS)-thalidomide crystal

(2010) Toshiya Suzuki et al.   PHASE TRANSITIONS

Thalidomide-induced limb defects: resolving a 50-year-old puzzle

(2009) Neil Vargesson   BIOESSAYS

Solid state evaluation of some thalidomide raw materials

(2009) J.P. Carini et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

(2009) C. Therapontos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA